Press Archive - Stand Up To Cancer

Press

Read the latest Stand Up To Cancer press releases and announcements to see how we are making an impact.

PRESS RELEASES

March 5, 2020

The Pancreatic Cancer Collective Extends Four Research Teams in $16 Million Push for New Therapies

The Pancreatic Cancer Collective, the strategic partnership of Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded additional funding of up to $16 million to four teams of top researchers as part of its “New Therapies Challenge Grants,” the American Association for Cancer Research (AACR), Scientific Partner of SU2C, announced today.
Read More
January 28, 2020

Stand Up To Cancer Awards 2020 Laura Ziskin Prize in Translational Research To Drs. Leisha A. Emens and Xiang Zhang

Stand Up To Cancer (SU2C) has awarded the 2020 Laura Ziskin Prize in Translational Research to two highly respected clinical investigators who will come together in a novel collaboration between leaders in breast cancer immuno-oncology and tumor immunology for research to further the availability of immune checkpoint inhibitors for breast cancer patients. Dr. Leisha A. Emens, MD, PhD of UPMC Hillman Cancer Center, and Dr. Xiang Zhang, PhD of Baylor College of Medicine will share a $250,000 grant for their year-long research project which was awarded today at the 2020 SU2C Scientific Summit in Santa Monica.
Read More
January 27, 2020

Stand Up To Cancer Announces International Team on Early Detection of Gastric Cancer, World’s 3rd Leading Cause of Cancer Death

Stand Up To Cancer (SU2C) announced today that an international team of experts will take a new approach to fighting the world’s third-leading cause of cancer death -- stomach (or gastric) cancer.
Read More
January 27, 2020

Stand Up To Cancer Announces First-of-Its-Kind Initiative to Increase Diversity in Cancer Clinical Trials

Stand Up To Cancer (SU2C) announced today a groundbreaking initiative to increase minority representation in cancer clinical trials. All future SU2C-supported research grant proposals will now be required to include and address crucial issues related to recruitment and retention of patients from ethnic groups to improve diverse participation in cancer clinical trials. The announcement was made at Stand Up To Cancer’s annual Scientific Summit, which is attended by SU2C’s leadership and 300+ prominent cancer researchers representing each of SU2C’s Dream Teams, Research Teams and individual grants.
Read More
January 27, 2020

Dr. Laurie Glimcher Named to Stand Up To Cancer Scientific Advisory Committee

Stand Up To Cancer (SU2C) with its Scientific Partner, the American Association of Cancer Research (AACR), announced Laurie H. Glimcher, MD, President and CEO of the Dana-Farber Cancer Institute, Director of the Dana-Farber/Harvard Cancer Center and the Richard and Susan Smith Professor of Medicine at Harvard Medical School as the newest member of the SU2C Scientific Advisory Committee (SAC). Dr. Glimcher was introduced as the SAC’s newest member at the SU2C annual Scientific Summit in Santa Monica.
Read More
January 13, 2020

Cancer Patients and Survivors Invited to Submit Original Music Compositions to Compete for $2500 USD “Music As Healing” Grants from the Stand Up To Cancer Canada Kate McGarrigle Fund

The Stand Up To Cancer Canada Kate McGarrigle Fund announced today the “Music As Healing” Grant Program, an initiative that will encourage both cancer patients and cancer survivors, to share their cancer journey through original music compositions.
Read More
October 7, 2019

Stand Up To Cancer Congratulates Dr. William G. Kaelin, Jr., SU2C Scientific Leader for 2019 Nobel Prize for Medicine or Physiology

Stand Up To Cancer (SU2C) today congratulated William G. Kaelin, Jr., MD, member of the SU2C Scientific Advisory Committee (SU2C SAC), on receiving the Nobel Prize for Medicine or Physiology for his discovery of how cells sense and adapt to oxygen availability.
Read More
October 3, 2019

TGen-HonorHealth Clinical Trial Shows Tumor Shrinkage in 71 percent of Patients with Late-Stage Pancreatic Cancer

Adding a drug that targets a molecular vulnerability in pancreatic cancer could provide substantial benefit to patients, according to a clinical trial study by the HonorHealth Research Institute and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
Read More
September 20, 2019

American Airlines and Stand Up To Cancer Team Up With Hyatt, Universal Orlando Resort to Give Families Affected by Cancer with Weekend to Remember

Today marks the inaugural flight of the American Airlines official Stand Up To Cancer Airbus 321 that features 22,627 names of cancer survivors, patients and those we have lost to cancer. Names were submitted by the public throughout the month of July, all of whom donated $25 or more to have their loved one’s name added to the plane, resulting in more than $825,000 for cancer research.
Read More
September 16, 2019

Stand Up To Cancer Launches Two Research Teams To Accelerate Clinical Trials for Triple-negative Breast Cancer and Metastatic Prostate Cancer

Stand Up To Cancer (SU2C) is launching teams of experts to lead innovative attacks on two types of cancer that have defied conventional treatment: triple-negative breast cancer (TNBC) in women and metastatic prostate cancer in men.
Read More

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.